Survey Probes Barriers to Long-Acting Injectable PrEP for MSM
Fear of potential severe side effects may be the greatest barrier to long-acting injectable HIV prevention among men who have sex with men (MSM), followed by out-of-pocket costs, a researcher said. When examining relative importance of perceived barriers to long-acting injectable pre-exposure prophylaxis (PrEP), perceived side effects was the most important, representing 52% of the […]
HIV Independently Tied to More Severe COVID-19
HIV was independently associated with a higher risk for severe or critical COVID-19, according to a World Health Organization (WHO) analysis. In a study of people living with HIV in Asia, Europe, Africa, and South America who also were hospitalized for COVID-19, HIV infection was linked with an increased risk of severe or critical COVID-19 […]
Tenofovir Treatment Lessened Risk of Severe COVID Infection in HBV
Treatment with tenofovir reduced the risk of severe COVID-19 infection among patients with chronic hepatitis B virus (HBV), a researcher reported. In the database study of adults with HBV already on tenofovir (Biktarvy) or entecavir at 28 Spanish hospitals, patients on tenofovir had a 6% lower risk of developing severe COVID-19 versus 36% of those […]